IBM today announced the launch of services intended to furnish researchers with resources to fight the novel coronavirus. The company made molecules identified by AI as therapeutic candidates available under an open license, and it introduced a free version of its Functional Genomics Platform to support genome features discovery. Additionally, it provided free access to over 1,000 pieces of evidence-based curated COVID-19 and infectious disease content, and it rolled out an AI search engine trained on the COVID-19 Open Research Dataset to allow researchers to quickly find answers to questions.
- Google’s AI teaches robots how to move by watching dogs
- Researchers’ AI recommends lockdown strategies to curb coronavirus